Lv6
2910 积分 2021-05-19 加入
A Phase II study on the safety and efficacy of a single dose of pegfilgrastim for mobilization and transplantation of autologous hematopoietic stem cells in pediatric oncohematology patients
9天前
已完结
Impact of relative dose intensity of R-CCOP regimen in elderly patients with diffuse large B-cell lymphoma in China
17天前
已完结
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022
23天前
已完结
Clinical effect of prophylactic pegfilgrastim in patients with newly diagnosed acute lymphoblastic leukemia who receive intensive chemotherapy
24天前
已完结
肿瘤化疗所致血小板减少症诊疗中国专家共识(2018版)
26天前
已完结
HMPL-306 in relapsed or refractory IDH1- and/or IDH2-mutated acute myeloid leukemia: A phase 1 study
1个月前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
1个月前
已完结
Myelodysplastic syndromes: 2023 update on diagnosis, risk‐stratification, and management
1个月前
已完结
Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance
1个月前
已完结
Treatment intensification with FLAG‐Ida may improve disease control in younger patients with secondary acute myeloid leukaemia: long‐term follow up of the MRC AML15 trial
1个月前
已完结
皖公网安备34019202002308
